
Research
HealthExperimental drug can sharply reduce amyloid beta’s impact on Alzheimer’s
Northwestern’s NU-9 drug cuts a newly found toxic amyloid subtype and early brain inflammation, offering hope for pre-symptom Alzheimer’s care.
Joseph Shavit
















